Senzime AB (publ)
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive … Read more
Senzime AB (publ) (SNZZF) - Total Liabilities
Latest total liabilities as of June 2025: $63.82 Million USD
Based on the latest financial reports, Senzime AB (publ) (SNZZF) has total liabilities worth $63.82 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Senzime AB (publ) - Total Liabilities Trend (2013–2024)
This chart illustrates how Senzime AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Senzime AB (publ) Competitors by Total Liabilities
The table below lists competitors of Senzime AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
West Wits Mining Limited
PINK:WMWWF
|
USA | $5.88 Million |
|
Regis Corporation Common Stock
NYSE:RGS
|
USA | $399.61 Million |
|
STPCF
OTCGREY:STPCF
|
USA | $11.25 Million |
|
Aft Pharmaceuticals Ltd
AU:AFP
|
Australia | AU$73.04 Million |
|
Freightos Limited Ordinary shares
NASDAQ:CRGO
|
USA | $22.40 Million |
|
Verde Resources Inc
OTCQB:VRDR
|
USA | $1.48 Million |
|
Muhibbah Engineering M Bhd
KLSE:5703
|
Malaysia | RM1.60 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Senzime AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Senzime AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Senzime AB (publ) (2013–2024)
The table below shows the annual total liabilities of Senzime AB (publ) from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $78.67 Million | +35.49% |
| 2023-12-31 | $58.06 Million | -4.46% |
| 2022-12-31 | $60.78 Million | +152.80% |
| 2021-12-31 | $24.04 Million | -12.72% |
| 2020-12-31 | $27.55 Million | +14.45% |
| 2019-12-31 | $24.07 Million | -19.10% |
| 2018-12-31 | $29.75 Million | +16.33% |
| 2017-12-31 | $25.57 Million | +4.63% |
| 2016-12-31 | $24.44 Million | +1126.34% |
| 2015-12-31 | $1.99 Million | -26.37% |
| 2014-12-31 | $2.71 Million | +131.64% |
| 2013-12-31 | $1.17 Million | -- |